BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25831062)

  • 1. PTPRD is homozygously deleted and epigenetically downregulated in human hepatocellular carcinomas.
    Acun T; Demir K; Oztas E; Arango D; Yakicier MC
    OMICS; 2015 Apr; 19(4):220-9. PubMed ID: 25831062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.
    Wong CM; Ng YL; Lee JM; Wong CC; Cheung OF; Chan CY; Tung EK; Ching YP; Ng IO
    Hepatology; 2007 May; 45(5):1129-38. PubMed ID: 17464989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIP1 is downregulated in hepatocellular carcinoma by promoter hypermethylation.
    Acun T; Oztas E; Yagci T; Yakicier MC
    BMC Cancer; 2011 Jun; 11():223. PubMed ID: 21645397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic inactivation of T-cadherin in human hepatocellular carcinoma cells.
    Chan DW; Lee JM; Chan PC; Ng IO
    Int J Cancer; 2008 Sep; 123(5):1043-52. PubMed ID: 18553387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells.
    Zhang C; Li H; Zhou G; Zhang Q; Zhang T; Li J; Zhang J; Hou J; Liew CT; Yin D
    J Pathol; 2007 Jun; 212(2):134-42. PubMed ID: 17471463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylome analysis and integrative profiling of human HCCs identify novel protumorigenic factors.
    Neumann O; Kesselmeier M; Geffers R; Pellegrino R; Radlwimmer B; Hoffmann K; Ehemann V; Schemmer P; Schirmacher P; Lorenzo Bermejo J; Longerich T
    Hepatology; 2012 Nov; 56(5):1817-27. PubMed ID: 22689435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic inactivation of the tumor suppressor gene RIZ1 in hepatocellular carcinoma involves both DNA methylation and histone modifications.
    Zhang C; Li H; Wang Y; Liu W; Zhang Q; Zhang T; Zhang X; Han B; Zhou G
    J Hepatol; 2010 Nov; 53(5):889-95. PubMed ID: 20675009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent epigenetic silencing of the PTPRD tumor suppressor in laryngeal squamous cell carcinoma.
    Szaumkessel M; Wojciechowska S; Janiszewska J; Zemke N; Byzia E; Kiwerska K; Kostrzewska-Poczekaj M; Ustaszewski A; Jarmuz-Szymczak M; Grenman R; Wierzbicka M; Bartochowska A; Szyfter K; Giefing M
    Tumour Biol; 2017 Mar; 39(3):1010428317691427. PubMed ID: 28345455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma.
    Zhou X; Popescu NC; Klein G; Imreh S
    Cancer Genet Cytogenet; 2007 Aug; 177(1):6-15. PubMed ID: 17693185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of tumor suppressor A kinase anchor protein 12 in human hepatocarcinogenesis by epigenetic mechanisms.
    Goeppert B; Schmezer P; Dutruel C; Oakes C; Renner M; Breinig M; Warth A; Vogel MN; Mittelbronn M; Mehrabi A; Gdynia G; Penzel R; Longerich T; Breuhahn K; Popanda O; Plass C; Schirmacher P; Kern MA
    Hepatology; 2010 Dec; 52(6):2023-33. PubMed ID: 20979053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A catalog of genes homozygously deleted in human lung cancer and the candidacy of PTPRD as a tumor suppressor gene.
    Kohno T; Otsuka A; Girard L; Sato M; Iwakawa R; Ogiwara H; Sanchez-Cespedes M; Minna JD; Yokota J
    Genes Chromosomes Cancer; 2010 Apr; 49(4):342-52. PubMed ID: 20073072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution ArrayCGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma.
    Giefing M; Zemke N; Brauze D; Kostrzewska-Poczekaj M; Luczak M; Szaumkessel M; Pelinska K; Kiwerska K; Tönnies H; Grenman R; Figlerowicz M; Siebert R; Szyfter K; Jarmuz M
    Genes Chromosomes Cancer; 2011 Mar; 50(3):154-66. PubMed ID: 21213369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
    Long XR; He Y; Huang C; Li J
    Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H; Zhou F; Nie D; Chen Q; Cai X; Shan X; Zhou Z; Chen K; Huang A; Li S; Tang N
    Oncogene; 2014 May; 33(22):2826-35. PubMed ID: 23770846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of SFRP1 as a putative tumor suppressor gene can contribute to human hepatocellular carcinoma.
    Huang J; Zhang YL; Teng XM; Lin Y; Zheng DL; Yang PY; Han ZG
    BMC Cancer; 2007 Jul; 7():126. PubMed ID: 17626620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HLJ1 (DNAJB4) Gene Is a Novel Biomarker Candidate in Breast Cancer.
    Acun T; Doberstein N; Habermann JK; Gemoll T; Thorns C; Oztas E; Ried T
    OMICS; 2017 May; 21(5):257-265. PubMed ID: 28481734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic identification of ubiquitin carboxyl-terminal hydrolase L1 as a functional tumor suppressor and biomarker for hepatocellular carcinoma and other digestive tumors.
    Yu J; Tao Q; Cheung KF; Jin H; Poon FF; Wang X; Li H; Cheng YY; Röcken C; Ebert MP; Chan AT; Sung JJ
    Hepatology; 2008 Aug; 48(2):508-18. PubMed ID: 18666234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of the alcohol dehydrogenase 1B (ADH1B) and ADH1C genes by DNA methylation and histone deacetylation.
    Dannenberg LO; Chen HJ; Tian H; Edenberg HJ
    Alcohol Clin Exp Res; 2006 Jun; 30(6):928-37. PubMed ID: 16737450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.